Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Pepto Nausea Motion Sickness Meclizine HCl 25 mg Tablet — NDC 84126-340-03 (Billing 84126-0340-03)
by THE PROCTER & GAMBLE MANUFACTURING COMPANY · 3 VIAL, PLASTIC in 1 CELLO PACK / 10 TABLET in 1 VIAL, PLASTIC
This is a package of Pepto Nausea Motion Sickness Meclizine HCl 25 mg Tablet from THE PROCTER & GAMBLE MANUFACTURING COMPANY, marketed since Mar 2025 and currently FDA-listed, this package's marketing is listed to end Sep 2028.
NDC 84126-0340-03
🏷️ FDA NDC (as labeled)
84126-340-03
billing pads the product segment with a zero
This package
Contains10 tablet in 1 vial, plastic
Pack sizes2 compare ↓
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Sep 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 84126-340-03 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 84126 labeler · 340 product · 03 package
- Package marketed since
- Mar 3, 2026
- Package marketing ended
- Sep 1, 2028
- Sample package
- No — commercial package
- Barcode (UPC)
- 0301490003732
- FDA record last changed
- Sep 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
84126-340-03
Product NDC
84126-340
11-digit billing NDC
84126034003
UNII
HDP7W44CIO
UPC
0301490003732
Application #
M009
SPL Set ID
29a1bd1e-d0e0-478f-e063-6394a90ab0aa
Established class (EPC)
Antiemetic
Physiologic effect
Emesis Suppression
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2025-03-03
Marketing end
2028-09-01
Route
ORAL
Dosage form
TABLET
Substance
MECLIZINE HYDROCHLORIDE
Quick answers
- RxCUI (RxNorm): 995666
Why two NDCs?
The FDA registers this code as 84126-340-03 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 84126-0340-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Antiemetic class.
Pharmacologic class
Antiemetic
Drug family (ATC)
Piperazine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
📗 Our plain-language guide HelloPharmacist
- Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
- For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
- Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
- This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
💬 Questions about Meclizine HCl?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
10 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 6, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 84126-0340-01 84126-340-01 Main listing | 1 VIAL, PLASTIC in 1 CARTON / 10 TABLET in 1 VIAL, PLASTIC | 2025-03-03 | Sep 1, 2028 | Active |
| 84126-0340-03 You're viewing this | 3 VIAL, PLASTIC in 1 CELLO PACK / 10 TABLET in 1 VIAL, PLASTIC | 2026-03-03 | Sep 1, 2028 | Active |
Pack size FAQ
What quantity is in this package?
This package is listed by the FDA — 3 vial, plastic in 1 cello pack / 10 tablet in 1 vial, plastic.
What NDC number is used to bill for this package of Pepto Nausea Motion Sickness Meclizine HCl 25 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Meclizine Hydrochloride 25 mg 00904-7376-61 | Major | 100 tablets | $0.076 | AA | Availability likely | — |
| Meclizine Hydrochloride 25 mg 16571-0661-01 | Rising | 100 tablets | $0.076 | — | Availability likely | — |
| Meclizine Hydrochloride 25 mg 50268-0523-15 | AvPAK | 50 tablets | $0.076 | AA | Availability likely | — |
| Meclizine Hydrochloride 25 mg 53746-0442-01 | Amneal | 100 tablets | $0.076 | AA | Availability likely | — |
| Meclizine Hydrochloride 25 mg 59651-0808-01 | Aurobindo | 100 tablets | $0.076 | AA | Availability likely | — |
| Meclizine Hydrochloride 25 mg 60687-0730-01 | American | 100 tablets | $0.076 | AA | Availability likely | — |
| Meclizine Hydrochloride 25 mg 62135-0953-90 | Chartwell | 90 tablets | $0.076 | AA | Availability likely | — |
| Meclizine Hydrochloride 25 mg 70710-1162-00 | Zydus | 1000 tablets | $0.076 | AA | Availability likely | — |
| Meclizine Hydrochloride 25 mg 42806-0014-01 | Epic | 100 tablets | $0.078 | AA | Availability likely | — |
| Meclizine Hydrochloride 25 mg 59746-0121-06 | Jubilant | 100 tablets | $0.080 | AA | Availability likely | — |
| Meclizine Hydrochloride 25 mg 24689-0139-01 | APNAR | 100 tablets | $0.128 | — | Availability likely | — |
| Meclizine Hydrochloride 25 mg 24689-0146-01 | APNAR | 100 tablets | $0.128 | — | Availability likely | — |
| Motion Sickness Relief 25 mg 46122-0535-51 | Amerisource | 8 tablets | $0.128 | — | Availability likely | — |
| Motion Sickness Relief 25 mg 70000-0097-01 | Cardinal | 32 tablets | $0.128 | — | Availability likely | — |
| Motion Sickness 25 mg 70677-1088-01 | Strategic | 8 tablets | $0.128 | — | Availability likely | — |
| Motion Sickness Relief 25 mg 00363-4030-21 | Walgreen | 16 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 00615-8515-39 | NCS | 30 tablets | — | AA | FDA listed | — |
| PhysiciansCare Motion Sickness 25 mg 00924-1008-00 | Acme | 2 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 11673-0356-08 | TARGET | 8 tablets | — | — | FDA listed | — |
| Less Drowsy Motion Sickness Relief 25 mg 11822-0775-09 | Rite | 8 tablets | — | — | FDA listed | — |
| Motion Sickness Relief Less Drowsy 25 mg 21130-0778-02 | Better | 12 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 30142-0943-19 | Kroger | 8 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 36800-0943-19 | Topco | 8 tablets | — | — | FDA listed | — |
| Motion Sickness 25 mg 37808-0903-12 | H | 100 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 41163-0304-02 | United | 12 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 41250-0930-19 | Meijer | 8 tablets | — | — | FDA listed | — |
| Meclizine Hydrocloride 25 mg 42708-0102-30 | QPharma | 30 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 42708-0127-30 | QPharma | 30 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 42708-0189-30 | QPharma | 30 tablets | — | AA | FDA listed | — |
| Medique Medi-Meclizine 25 mg 47682-0481-15 | Unifirst | 1000 tablets | — | — | FDA listed | — |
| Less Drowsy Motion Sickness Relief 25 mg 49035-0403-19 | Wal-Mart | 8 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-5727-02 | A-S | 12 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-5728-00 | A-S | 20 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-7416-02 | A-S | 12 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 50090-7417-00 | A-S | 20 tablets | — | AA | FDA listed | — |
| Dramamine Less Drowsy Meclizine Hydrochloride 25 mg 50269-0526-00 | JC | 40 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 50844-0403-19 | L.N.K. | 8 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 51655-0107-20 | Northwind | 20 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 51655-0175-52 | Northwind | 30 tablets | — | AA | FDA listed | — |
| Motion Sickness 25 mg 55301-0403-21 | ARMY | 16 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 55319-0903-19 | Family | 8 tablets | — | — | FDA listed | — |
| Motion Sickness Relief 25 mg 55910-0943-19 | DOLGENCORP, | 8 tablets | — | — | FDA listed | — |
| Less Drowsy Formula Motion Sickness Relief 25 mg 57243-0403-02 | Salado | 12 tablets | — | — | FDA listed | — |
| Travel-Ease 25 mg 57896-0378-01 | Geri-Care | 100 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 60760-0661-30 | St. | 30 tablets | — | — | FDA listed | — |
| Dramamine Less Drowsy 25 mg 63029-0903-01 | Medtech | 8 tablets | — | — | FDA listed | — |
| Dramamine - N 25 mg 63029-0905-10 | Medtech | 10 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 63187-0258-10 | Proficient | 10 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 63187-0996-10 | Proficient | 10 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 65162-0442-03 | Amneal | 30 tablets | — | AA | FDA listed | — |
| Dramamine Less Drowsy, Lil Drug Store 25 mg 66715-9734-01 | Lil' | 2 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 67296-2138-02 | Redpharm | 21 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 67296-2205-02 | Redpharm | 21 tablets | — | AA | FDA listed | — |
| Dramamine Less Drowsy 25 mg 67751-0242-02 | Navajo | 2 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 68071-2380-02 | NuCare | 20 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 68071-2416-06 | NuCare | 6 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 68071-3017-01 | NuCare | 12 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 68071-3748-04 | NuCare | 4 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 68071-3791-02 | NuCare | 20 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 69842-0857-05 | CVS | 16 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 70518-1308-00 | REMEDYREPACK | 90 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 70518-3815-00 | REMEDYREPACK | 21 tablets | — | — | Discontinued | — |
| Meclizine Hydrochloride 25 mg 70771-1540-00 | Zydus | 1000 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 71205-0786-10 | Proficient | 10 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 71335-0503-00 | Bryant | 14 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 71335-1825-00 | Bryant | 14 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 72189-0237-30 | Direct_Rx | 30 tablets | — | — | Discontinued | — |
| Meclizine Hydrochloride 25 mg 76420-0130-10 | Asclemed | 10 tablets | — | AA | FDA listed | — |
| Meclizine Hydrochloride 25 mg 76420-0798-01 | Asclemed | 100 tablets | — | — | FDA listed | — |
| Nausea Relief 25 mg 79903-0177-10 | WALMART | 10 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 80425-0494-01 | Advanced | 30 tablets | — | — | FDA listed | — |
| Meclizine Hydrochloride 25 mg 82868-0058-20 | Northwind | 20 tablets | — | AA | FDA listed | — |
| Motion Sickness Relief 25 mg 83059-0007-01 | Shield | 15 tablets | — | — | FDA listed | — |
| Pepto Nausea Motion Sickness 25 mgthis 84126-0340-03 | THE | 10 tablets | — | — | FDA listed | — |
| Medique Medi-Meclizine 25 mg 85766-0175-00 | Sportpharm | 1000 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71335-1607-00 | Bryant | 120 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 71205-0606-30 | Proficient | 30 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 68788-7982-01 | Preferred | 10 tablets | — | — | FDA listed | — |
| Meclizine HCL 25 mg 69618-0028-01 | Reliable | 100 tablets | — | — | FDA listed | — |
| Pepto Motion Sickness 25 mg 84126-0380-01 | THE | 10 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2025
On the market since
Mar 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Color
pink
ShapeRound
ImprintPN
Size9 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
- FDA label on DailyMed · label index refreshed Oct 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Meclizine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 3SY5LH9PMK
Anhydrous lactose is a milk sugar with no water content. It acts as a filler and binder in tablets and capsules, adding bulk and helping ingredients stick together.
-
UNII 6T47AS764T
Red 40 Lake is a synthetic colorant made by combining Red 40 dye with aluminum hydroxide. It's used to give tablets, capsules, and other medicines a red or pink color for identification and appearance.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII O8232NY3SJ
A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
6 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesanhydrous lactose, corn starch, FD&C Red No. 40 Aluminum Lake, magnesium stearate, microcrystalline cellulose, silicon dioxide
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerTHE PROCTER & GAMBLE MANUFACTURING COMPANY
FDA applicationM009 (OTC MONOGRAPH DRUG)
Labeler code84126
First marketedMar 2025
Product typeHuman Otc Drug
Portfolio850 products on file
More NDCs from THE PROCTER & GAMBLE MANUFACTURING COMPANY labeler code 84126
- Rolaids Ultra Strength 1200 Calcium Carbonate, Magnesium Hydroxide 1000 mg; 200 mg Tablet, Chewable NDC 84126-322-10
- Vicks Herbal Drops Menthol 4.8 mg Lozenge NDC 84126-323-50
- Rolaids ORIGINAL Calcium carbonate and Magnesium hydroxide 675 mg; 135 mg Tablet, Chewable NDC 84126-324-03
- Rolaids ULTRA STRENGTH 1200 Calcium Carbonate, Magnesium Hydroxide 1000 mg; 200 mg Tablet, Chewable NDC 84126-325-10
- VICKS DayQuil NyQuil SEVERE HONEY COLD and FLU Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl and Doxylamine succinate Kit NDC 84126-326-24
- Olay Complete plus Principle Invisible Facial Primer plus Sunscreen Broad Spectrum SPF 35 Avobenzone, Homosalate, Octisalate, and Octocrylene 3 g/100mL; 10 g/100mL; 5 g/100mL; 10 g/100mL Lotion NDC 84126-330-60
- Vicks VapoCOOL Menthol 20 mg Lozenge NDC 84126-341-12
- Vicks NyQuil Cold and Flu Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate 650 mg/30mL; 30 mg/30mL; 12.5 mg/30mL Liquid NDC 84126-342-04
- Rolaids Heartburn plus Gas Calcium Carbonate, Magnesium Hydroxide, Simethicone 40 mg; 1000 mg; 200 mg Tablet, Chewable NDC 84126-343-01
- Vicks DayQuil Kids and Vicks NyQuil Kids COLD and COUGH plus FEVER Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine succinate Kit NDC 84126-344-16
- Vicks NyQuil Kids ALLERGY Doxylamine Succinate 6.25 mg/15mL Liquid NDC 84126-345-08
- Vicks NyQuil ALLERGY Doxylamine Succinate 6.25 mg/15mL Liquid NDC 84126-346-12
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🆘 Overdosage
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 Ask a Doctor Before Use If
📄 Ask a Doctor or Pharmacist Before Use If
📄 When Using This Product
🤰 If Pregnant or Breast-Feeding
📄 Keep Out of Reach of Children
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
⏱️ Dosage and Administration ▾
Directions take ½ to 1 hour before traveling adults and children 12 years and over: 1 to 2 tablets once daily or as directed by a doctor
⚠️ Warnings ▾
Warnings Do not use in children under 12 years of age unless directed by a doctor. Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma difficulty in urination due to enlargement of the prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness use caution when driving a motor vehicle or operating machinery If pregnant or breast feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
🆘 Overdosage ▾
In case of overdose, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active ingredient (in each tablet) Meclizine HCl 25 mg
🧪 Inactive Ingredients ▾
Inactive ingredients anhydrous lactose, corn starch, FD&C Red No. 40 Aluminum Lake, magnesium stearate, microcrystalline cellulose, silicon dioxide
🎯 Purpose ▾
Purpose Antiemetic
📄 Do Not Use ▾
Do not use in children under 12 years of age unless directed by a doctor.
📄 Ask a Doctor Before Use If ▾
Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma difficulty in urination due to enlargement of the prostate gland
📄 Ask a Doctor or Pharmacist Before Use If ▾
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
📄 When Using This Product ▾
When using this product drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness use caution when driving a motor vehicle or operating machinery
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast feeding, ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children.
📄 Questions or Comments ▾
Questions? 1-800-717-3786
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL Meclizine HCl - Antiemetic Pepto Nausea MOTION SICKNESS TARGETED RELIEF TREAT + PREVENT NAUSEA LESS DROWSY 10 TABLETS 340
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Meclizine HCl (matched by generic name) — the program that covers self-administered drugs. 8 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Meclizine HCl. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$6.73M
Claims incl. refills
748.9K
Beneficiaries
532.6K
Spend / beneficiary
$12.64
Spend / claim
$8.99
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Pepto Nausea Motion Sickness (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 27%
Female · 73%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but THE PROCTER & GAMBLE MANUFACTURING COMPANY has reported a marketing end date of 2028-09-01, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 10 tablets (84126-0340-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
THE PROCTER & GAMBLE MANUFACTURING COMPANY is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.